Otsuka Pharmaceutical Development & Commercialization

Last update: July 2, 2019

Pharmaceuticals
United States (USA) Its 16 main executives

Create an alert
to follow the executive moves at Otsuka Pharmaceutical Development & Commercialization.

Latest M&A news in Pharmaceuticals.

Elanco has announced the acquisition of Bayer Animal Health (posted on Aug 20, 2019).
Boston Scientific has acquired BTG (posted on Aug 19, 2019).
Glaukos has announced the acquisition of Avedro (posted on Aug 8, 2019).

Latest news about Otsuka Pharmaceutical Development & Commercialization

Otsuka Pharmaceutical Development & Commercialization on Wikipedia, Google News & Yahoo Finance

Otsuka Pharmaceutical Development & Commercialization on LinkedIn, Twitter & YouTube

Otsuka Pharmaceutical Development & Commercialization has 1,898 competitors including Johnson & Johnson (United States (USA)), Roche (Switzerland) and Novartis (Switzerland). Otsuka Pharmaceutical Development & Commercialization is owned by Otsuka Pharmaceutical.

The most constantly updated executive directory.

Companies

Companies

Learn about your clients' org charts. Understand their industries and their competitors.

Executives

Executives

View the executives' biographies. Contact the executives through our email platform.

Alerts

Alerts

Select key words to follow your clients. Receive alerts when executive movements happen.

Customers

Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.